An observational study in Japanese patients to evaluate the disease activity in patients with rheumatoid arthritis after switching from tumour necrosis factor inhibitors to abatacept

Trial Profile

An observational study in Japanese patients to evaluate the disease activity in patients with rheumatoid arthritis after switching from tumour necrosis factor inhibitors to abatacept

Completed
Phase of Trial: Phase II

Latest Information Update: 11 Feb 2016

At a glance

  • Drugs Abatacept (Primary)
  • Indications Rheumatoid arthritis
  • Focus Therapeutic Use
  • Most Recent Events

    • 11 Feb 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top